🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/03/1992 | 24,01 | 24,31 | 24,01 | 24,05 | +0,00% | 1,24% | 5.025.370 |
| 04/03/1992 | 24,47 | 24,49 | 23,84 | 24,05 | -1,71% | 2,68% | 8.561.741 |
| 03/03/1992 | 24,95 | 24,97 | 24,47 | 24,47 | -1,91% | 1,99% | 4.655.006 |
| 02/03/1992 | 25,05 | 25,13 | 24,87 | 24,95 | -0,48% | 1,03% | 4.001.683 |
| 28/02/1992 | 25,21 | 25,25 | 24,85 | 25,07 | -0,47% | 1,58% | 4.624.824 |
| 27/02/1992 | 25,31 | 25,45 | 25,09 | 25,19 | -0,16% | 1,41% | 7.355.074 |
| 26/02/1992 | 24,63 | 25,33 | 24,49 | 25,23 | +4,02% | 3,39% | 12.049.694 |
| 25/02/1992 | 23,99 | 24,25 | 23,95 | 24,25 | +2,01% | 1,24% | 5.188.858 |
| 24/02/1992 | 23,22 | 23,86 | 23,22 | 23,78 | +2,22% | 2,74% | 4.154.482 |
| 21/02/1992 | 23,46 | 23,62 | 23,02 | 23,26 | -0,68% | 2,54% | 6.984.710 |
| 20/02/1992 | 23,16 | 23,58 | 23,16 | 23,42 | +2,17% | 1,80% | 6.459.662 |
| 19/02/1992 | 23,20 | 23,22 | 22,82 | 22,92 | -1,28% | 1,71% | 8.766.730 |
| 18/02/1992 | 23,74 | 23,86 | 23,22 | 23,22 | -1,52% | 2,68% | 5.784.331 |
| 14/02/1992 | 23,89 | 23,91 | 23,56 | 23,58 | -1,82% | 1,50% | 6.823.738 |
| 13/02/1992 | 24,33 | 24,37 | 23,91 | 24,01 | -1,71% | 1,88% | 4.267.037 |
| 12/02/1992 | 24,35 | 24,53 | 24,21 | 24,43 | -0,16% | 1,31% | 4.012.373 |
| 11/02/1992 | 24,47 | 24,55 | 24,31 | 24,47 | +0,08% | 0,97% | 3.052.824 |
| 10/02/1992 | 24,41 | 24,69 | 24,41 | 24,45 | +0,16% | 1,14% | 3.549.576 |
| 07/02/1992 | 24,89 | 24,93 | 24,29 | 24,41 | -1,60% | 2,56% | 4.343.122 |
| 06/02/1992 | 25,07 | 25,09 | 24,53 | 24,81 | -1,34% | 2,22% | 4.997.074 |
| 05/02/1992 | 25,43 | 25,58 | 25,03 | 25,15 | -0,47% | 2,19% | 7.341.240 |
| 04/02/1992 | 24,51 | 25,27 | 24,51 | 25,27 | +2,92% | 3,08% | 5.639.078 |
| 03/02/1992 | 25,01 | 25,23 | 24,49 | 24,55 | -1,75% | 2,94% | 5.796.907 |
| 31/01/1992 | 24,87 | 25,19 | 24,85 | 24,99 | +1,21% | 1,36% | 5.165.592 |
| 30/01/1992 | 24,31 | 24,73 | 24,23 | 24,69 | +1,89% | 2,04% | 4.285.901 |
| 29/01/1992 | 24,33 | 24,93 | 24,17 | 24,23 | -0,41% | 3,10% | 7.614.139 |
| 28/01/1992 | 24,13 | 24,49 | 23,95 | 24,33 | +0,66% | 2,22% | 5.528.410 |
| 27/01/1992 | 24,49 | 24,55 | 24,09 | 24,17 | -0,98% | 1,87% | 4.396.570 |
| 24/01/1992 | 24,61 | 24,81 | 24,39 | 24,41 | -0,97% | 1,70% | 5.612.669 |
| 23/01/1992 | 24,73 | 25,01 | 24,57 | 24,65 | +0,08% | 1,77% | 6.201.854 |